Similar work in human heart samples from patients with pulmonary arterial hypertension identified key genes that change uniquely in RV failure, including increased FBN2 (which had a similar trend in our model), and CTGF (which was significantly increased in our model, FDR < 0.05). This evidence concerns the gene FBN2 and pulmonary arterial hypertension.